Antitrypanosomal isothiocyanate and thiocarbamate glycosides from <em>Moringa peregrina </em>[Letter] (Publications)
O-Methyl (1), O-ethyl (2), and O-butyl (3) 4-[(alpha-L-rhamnosyloxy) benzyl] thiocarbamate (E), along with 4-(alpha-L-rhamnosyloxy) benzyl isothiocyanate (4) have been isolated from the aerial parts o
Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD (Publications)
The enzymes of the non-mevalonate pathway for isoprenoid biosynthesis have been identified as attractive targets with novel modes of action for the development of herbicides for crop protection and ag
Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis (Publications)
BACKGROUND: Currently no valid surrogate marker exists for primary progressive multiple sclerosis (PPMS). OBJECTIVE: Our aim was to prospectively investigate multimodal evoked potentials (EPs) as mark
Luftverschmutzung und Gesundheit - Optionen in der klinischen Beratung (Publications)
While air quality is usually an environmental condition patients can little do about, there are a few options and decisions that modify the personal exposure and risk. Location - in particular the res
Glycerol-3-phosphate acyltransferases gat1p and gat2p are microsomal phosphoproteins with differential contributions to polarized cell growth (Publications)
Glycerol-3-phosphate acyltransferase (GPAT) catalyzes the initial step in the synthesis of all glycerolipids. It is the committed and rate-limiting step and is redundant in Saccharomyces cerevisiae, m
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy (Publications)
Several studies have shown that 11C-choline PET/CT may be useful for restaging prostate cancer (PCa) patients with biochemical failure after radical prostatectomy. However, validation of 11C-choline P
LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014 (Publications)
BACKGROUND: Treatment of cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML) in travelers is still controversial. Over the last decade, national and international consortia have published reco